Transcription of 2.7.3 summary of clinical efficacy
{{id}} {{{paragraph}}}
Example: tourism industry
2.7.3 summary of clinical efficacy
CONFIDENTIALCM2003/00031 summary of clinical efficacy - 1 -Module of clinical EfficacyCopyright 2003 the GlaxoSmithKline group of companies. All rights copying or use of this information is summary of clinical efficacy - 2 -TABLE OF CONTENTSPAGEMODULE .. AND OVERVIEW OF clinical efficacy .. Pharmacology and biopharmaceutics Studies .. Intracellular Carbovir Triphosphate Study .. ABC/3TC Fixed Dose CombinationBioequivalence Study Analysis .. efficacy endpoints .. efficacy endpoints .. GSK-Sponsored OF RESULTS OF INDIVIDUAL STUDIES.
CONFIDENTIAL CM2003/00031/00 2.7.3 Summary of Clinical Efficacy - 7 - 1.1. Clinical Pharmacology and Biopharmaceutics Studies 1.1.1. CNA10905 ΠIntracellular Carbovir Triphosphate Study
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: